![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Genzyme Acquires Verigen
Genzyme Acquires Verigen
Genzyme has acquired Verigen, a private company based in Germany with a proprietary cell therapy product for cartilage repair currently sold in Europe and Australia. This product, Matrix-induced Autologous Chondrocyte Implantation (MACI), will both expand Genzyme's orthopedic offerings in these markets, and provide a strong second generation product to develop for the U.S. market.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=18959120&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct